Core Insights - ArisGlobal has launched XDI, a Data Intelligence Cortex aimed at transforming regulated life sciences data into continuous, explainable, decision-grade intelligence across the product life-cycle [1] Group 1: Product Features - XDI addresses the challenge of managing fragmented data across disparate systems, enabling organizations to generate consistent, explainable decisions [1] - The solution connects signals across domains, applies contextual learning, and delivers insights at decision-making points, allowing organizations to anticipate risks and opportunities [1] - XDI does not require data consolidation into a single platform, instead bringing intelligence to the data wherever it resides [1] Group 2: Operational Benefits - XDI's offerings include: - Regulatory operational intelligence, which can reduce compliance effort by 70-80% and quality control (QC) efforts by up to 75% through continuous checks [1] - Benefit-risk intelligence, enabling over 30% faster signal detection and up to 40% noise reduction in signal workflows, compressing cycle time from four to six weeks down to four days [1] - Pharmacovigilance operational intelligence, shifting operations from reactive to proactive, with similar reductions in compliance effort and QC [1] Group 3: Strategic Vision - The launch of XDI aligns with ArisGlobal's vision of evolving from an AI-first company to a data intelligence technology company in life sciences [1] - The focus for life sciences organizations in 2026 is on operationalizing AI at scale and leveraging cross-domain data intelligence [1] - XDI is built on the "Trust by Design" framework, integrating AI governance and ensuring regulatory defensibility across the AI lifecycle [1]